Genmab A (GMAB) Current Taxes (2023 - 2025)

Genmab A (GMAB) has disclosed Current Taxes for 3 consecutive years, with $43.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Taxes fell 82.01% year-over-year to $43.0 million, compared with a TTM value of $43.0 million through Dec 2025, down 82.01%, and an annual FY2025 reading of $43.0 million, down 82.01% over the prior year.
  • Current Taxes was $43.0 million for Q4 2025 at Genmab A, down from $239.0 million in the prior quarter.
  • Across five years, Current Taxes topped out at $239.0 million in Q4 2024 and bottomed at $8.0 million in Q4 2023.
  • Average Current Taxes over 3 years is $96.7 million, with a median of $43.0 million recorded in 2025.
  • The sharpest move saw Current Taxes soared 2887.5% in 2024, then plummeted 82.01% in 2025.
  • Year by year, Current Taxes stood at $8.0 million in 2023, then skyrocketed by 2887.5% to $239.0 million in 2024, then tumbled by 82.01% to $43.0 million in 2025.
  • Business Quant data shows Current Taxes for GMAB at $43.0 million in Q4 2025, $239.0 million in Q4 2024, and $8.0 million in Q4 2023.